Supreme Court orders panel to review unethical pharma marketing

The Supreme Court directed the Centre to form a three-member committee to examine statutory regulation of pharmaceutical marketing, including gifts and benefits offered to doctors. The panel will consider stakeholder views and recommend measures against unethical practices. The Centre must submit a compliance affidavit before the next hearing on January 29.